ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia

Clinical Pharmacology and Therapeutics

Volumn 69, Issue 1, 2001, Pages 66-71

  Liu, Spencer S ^a   Hodgson, Peter S ^a   Carpenter, Randall L ^a   Fricke Jr , James R ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIMETHYL 4 (3 HYDROXYPHENYL)PIPERIDINE DERIVATIVE; ALVIMOPAN; LACTULOSE; MORPHINE; OPIATE ANTAGONIST; PIPERIDINE DERIVATIVE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRANSIT; HUMAN; HYDROGEN BREATH TEST; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PUPIL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANALGESICS, OPIOID; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRANSIT; HUMANS; MALE; MOLAR, THIRD; MORPHINE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PIPERIDINES; TOOTH EXTRACTION; TOOTH, IMPACTED;

EID: 0035138992     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2001.112680     Document Type: Article

References (18)

1. Opioid-induced delay in gastric emptying: A peripheral mechanism in humans
2. Gut motility mid transit changes in patients receiving long term methadone maintenance
3. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time
4. Methylnaltrexone: Reversing the gastrointestinal effects of opioids
5. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites
6. Assessment of nalmefene glucuronide as a selective gut opioid antagonist
7. Treatment of opioid-induced constipation with oral naloxone: A pilot study
8. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer
9. Oral naloxone reverses opioid-associated constipation
10. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: A double-blind randomized placebo-controlled trial
11. Methylnaltrexone for reversal of constipation due to chronic methadone use
12. LY246736 Dihydrate. Mu opioid receptor antagonist
13. Discovery of a potent, peripherally selective trans-3,4,dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders
14. Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit
15. Evaluation of a new photographic method for assessing pupil diameters
16. Analgesic efficacy of a combination of hydrocodone with ibuprofen in postoperative pain
17. Influence of the substrate on the reproducibility of the hydrogen breath test to measure the orocecal transit time
18. The lactulose hydrogen breath test as a measure of orocaecal transit time